• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Glob Antimicrob Resist . Molecular identification of Neuraminidase Gene Mutations in Influenza A/H1N1 and A/H3N2 Isolates of Mazandaran province,

tetano

Editor, Senior Moderator
J Glob Antimicrob Resist


. 2023 Nov 20:S2213-7165(23)00197-2.
doi: 10.1016/j.jgar.2023.10.025. Online ahead of print. Molecular identification of Neuraminidase Gene Mutations in Influenza A/H1N1 and A/H3N2 Isolates of Mazandaran province, north of Iran

Mehdi Rabie-Rudsari[SUP] 1 [/SUP], Emad Behboudi[SUP] 2 [/SUP], Ategheh Ranjkesh[SUP] 3 [/SUP], Kimia Kaveh[SUP] 1 [/SUP], Hadi Razavi-Nikoo[SUP] 1 [/SUP], Mohammad Reza Haghshenas[SUP] 4 [/SUP], Abdolvahab Moradi[SUP] 5 [/SUP]



Affiliations
Abstract

Objectives: The neuraminidase (NA) mutations causing resistance to NA inhibitors (NAIs) mostly compromise the fitness of influenza viruses. Considering the importance of these mutations, constant monitoring of the effectiveness of available drugs is critical. This study aimed to identify NA mutations in the influenza A/H1N1 and A/H3N2 subtypes in the samples of Mazandaran, Iran from 2016 to 2020.
Methods: In this cross-sectional study, 20 influenza A/H1N1 and 20 influenza A/H3N2 samples were included in the study. After design of appropriate primers for NA gene, all samples subjected to RT-PCR and electrophoresis. Then the PCR product was sequenced to determine the mutations.
Results: In the present study, no oseltamivir resistance related mutations was detected. Still, NA gene showed variations compared to the vaccine strains. In A/H1N1 a total of 43 mutations were detected. Similarly, in A/H3N2, a total of 66 mutations were observed. In all isolates of H1N1, N200S, N248D and I321V mutations were detected in the antigenic site of NA protein, which can affect vaccine incompatibility and virus escape from the host's immune system. Also, H150R mutation was observed in the NA active site of H3N2, which is the cause of agglutination by NA protein. Also, S245N mutation was identified as a new N-Glycosylation site of H3N2 subtype.
Conclusion: The study of NA gene sequences, revealed no oseltamivir resistance mutations. In H1N1 isolates, approximately 97% identities and in the H3N2 subtype, 96% identity was observed compared to reference isolate of 2009, which indicates the importance of constant monitoring of the emergence of the drug resistance mutations.

Keywords: A/H1N1; A/H3N2; Influenza A; drug resistance; mutation.

 
Back
Top Bottom